Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders.
about
Individual Differences in Behavioural Despair Predict Brain GSK-3beta Expression in Mice: The Power of a Modified Swim Test.Novel Non-phosphorylated Serine 9/21 GSK3β/α Antibodies: Expanding the Tools for Studying GSK3 RegulationMarine Fungi as Producers of Benzocoumarins, a New Class of Inhibitors of Glycogen-Synthase-Kinase 3β.Microtubule and microtubule associated protein anomalies in psychiatric disease.Immunotherapies for neurodegenerative diseases: current status and potential of plant-made biopharmaceuticals.Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015).Modulation of AβPP and GSK3β by Endoplasmic Reticulum Stress and Involvement in Alzheimer's Disease.Lithium increases synaptic GluA2 in hippocampal neurons by elevating the δ-catenin protein.GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus
P2860
Q27312769-E3AABB81-B3B9-4758-93AE-53FB92EB37B5Q37418678-8649E179-C69A-4819-A2C5-DCCC618CD93FQ37453610-12009EE0-3BA5-42B2-9D8C-6451845FE3B6Q38817194-C8380794-970A-40AF-99C0-FD46AD7D991FQ38942195-B282962B-E507-44DD-839A-F3802E68F28DQ39003757-1CCA7659-70C6-42BB-AA01-913816EA48F3Q39198755-F581E201-CBBA-4BE3-8AD5-05BC492933FAQ48452047-908808C2-2E8B-47DF-B94B-626B8201A5BBQ57477426-0C8EF8AA-83BA-487D-9F5B-FF14D7B1F370Q58712518-27762CDD-0A6A-46A2-BA14-F536AD06E16E
P2860
Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Glycogen synthase kinase-3 as ...... in neuropsychiatric disorders.
@en
type
label
Glycogen synthase kinase-3 as ...... in neuropsychiatric disorders.
@en
prefLabel
Glycogen synthase kinase-3 as ...... in neuropsychiatric disorders.
@en
P2860
P1433
P1476
Glycogen synthase kinase-3 as ...... in neuropsychiatric disorders
@en
P2093
Olivia O'Leary
Yvonne Nolan
P2860
P2888
P356
10.1007/S40263-014-0213-Z
P577
2015-01-01T00:00:00Z